Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial.
Ardon H, Van Gool SW, Verschuere T, Maes W, Fieuws S, Sciot R, Wilms G, Demaerel P, Goffin J, Van Calenbergh F, Menten J, Clement P, Debiec-Rychter M, De Vleeschouwer S. Ardon H, et al. Among authors: van gool sw, van calenbergh f. Cancer Immunol Immunother. 2012 Nov;61(11):2033-44. doi: 10.1007/s00262-012-1261-1. Epub 2012 Apr 22. Cancer Immunol Immunother. 2012. PMID: 22527250 Clinical Trial.
Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report.
De Vleeschouwer S, Van Calenbergh F, Demaerel P, Flamen P, Rutkowski S, Kaempgen E, Wolff JE, Plets C, Sciot R, Van Gool SW. De Vleeschouwer S, et al. Among authors: van gool sw, van calenbergh f. J Neurosurg. 2004 May;100(5 Suppl Pediatrics):492-7. doi: 10.3171/ped.2004.100.5.0492. J Neurosurg. 2004. PMID: 15287461
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme.
De Vleeschouwer S, Fieuws S, Rutkowski S, Van Calenbergh F, Van Loon J, Goffin J, Sciot R, Wilms G, Demaerel P, Warmuth-Metz M, Soerensen N, Wolff JE, Wagner S, Kaempgen E, Van Gool SW. De Vleeschouwer S, et al. Among authors: van loon j, van gool sw, van calenbergh f. Clin Cancer Res. 2008 May 15;14(10):3098-104. doi: 10.1158/1078-0432.CCR-07-4875. Clin Cancer Res. 2008. PMID: 18483377 Free article. Clinical Trial.
Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study.
Ardon H, Van Gool S, Lopes IS, Maes W, Sciot R, Wilms G, Demaerel P, Bijttebier P, Claes L, Goffin J, Van Calenbergh F, De Vleeschouwer S. Ardon H, et al. Among authors: van gool s, van calenbergh f. J Neurooncol. 2010 Sep;99(2):261-72. doi: 10.1007/s11060-010-0131-y. Epub 2010 Feb 10. J Neurooncol. 2010. PMID: 20146084
Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination.
De Vleeschouwer S, Ardon H, Van Calenbergh F, Sciot R, Wilms G, van Loon J, Goffin J, Van Gool S. De Vleeschouwer S, et al. Among authors: van gool s, van loon j, van calenbergh f. Cancer Immunol Immunother. 2012 Nov;61(11):2105-12. doi: 10.1007/s00262-012-1271-z. Epub 2012 May 8. Cancer Immunol Immunother. 2012. PMID: 22565485
Defining pseudoprogression in glioblastoma multiforme.
Van Mieghem E, Wozniak A, Geussens Y, Menten J, De Vleeschouwer S, Van Calenbergh F, Sciot R, Van Gool S, Bechter OE, Demaerel P, Wilms G, Clement PM. Van Mieghem E, et al. Among authors: van gool s, van calenbergh f. Eur J Neurol. 2013 Oct;20(10):1335-41. doi: 10.1111/ene.12192. Epub 2013 May 17. Eur J Neurol. 2013. PMID: 23679051
Long-term survival in a child with a brain stem dermoid cyst.
van Calenbergh F, Demaerel P, Sciot R, van Gool S. van Calenbergh F, et al. Among authors: van gool s. Surg Neurol. 2005 Mar;63(3):261-3; discussion 263-4. doi: 10.1016/j.surneu.2004.04.019. Surg Neurol. 2005. PMID: 15734520
148 results